Overview of Poster Sessions

P1. Effects of neonatal dopaminergic depletion on the developmental interactions of monoaminergic systems. CM Connor, MG Cunningham, K Zhang, FM Benes

P2. Decreased cerebral blood flow in middle-stage Huntington's disease patients occurs immediately prior to the onset of chorea. A Deckel, A Nwankpah, S Williams

P3. Motor fluctuations during continuous levodopa infusion in six patients with Parkinson's disease. SA Frank, K LaDonna, A Justus, R Kurlan, IH Richard

P4. A graphic model of the central nervous system regulation complex. WA Marcil, DR Wilson

P5. Brain-behavior correlations in frontotemporal dementia and Alzheimer's disease: positive findings using MRI volumetry from the Sunnybrook Dementia Study. C Bocti, F-Q Gao, SE Black

P6. Caregiver perception of executive dysfunction and behavioral problems as a predictor of burden in dementia caregivers. JD Davis, G Tremont, CM Slavin, S Salloway

P7. The correlates of subjective suffering in patients diagnosed with Huntington's disease. J Duffy, B Hennig, MJ Fitzpatrick, K Tanev, AW Deckel

P8. Correlates of apathy in early-stage and midstage Huntington's disease. JD Duffy, B Hennig, K Tanev, MJ Fitzpatrick, AW Deckel

P9. Role of dementia in unmasking behavioral effects of longstanding right amygdala lesion: a neuropsychiatric case study. A Newman, VE Koliatsos

P10. Prediction of on-road driving performance by patients with mild dementia. BR Ott, LB Brown, GD Papandonatos, Y Sui, T Souza, MC Lannon, C Maxwell, JC Morris

P11. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. AJ Saykin, HA Wishart, LA Rabin, LA Flashman, TL McHugh, AC Mamourian, RB Santulli

P12. Sensitive detection of mild cognitive impairment using the Tape-Administered Cognitive Screen. P Schofield, S Lee

P13. Clinical usefulness for differential diagnosis of elderly depressed patients using three-dimensional stereotactic surface projections of 123I-IMP SPECT. K Shimoda, M Kimura, A Tateno, Y Okubo

P14. Is late-life depression a predictor of dementia? M Simard, R Van Reekum, D Clarke, L Jean, C Chayer, DK Conn, N Herrmann, HS Mayberg, D Rewilak, DT Stuss

P15. New onset psychosis following recent seizure cessation with vagus nerve stimulation. SA Jumaa, L McClintock, J Patterson, A Kablinger, J DellaBadia

P16. Psychiatric manifestations of frontal lobe epilepsy. EK Lee, TA Rummans, RC Colligan, EL So, MR Trenerry, MS Maurer, VS Pankratz

P17. Impact of lateralization of seizure focus on memory performance in a pediatric population compared to normal controls. SD O'Leary, KA Borden, TG Burns

P18. Incidence of traumatic brain injury in patients with video EEG confirmed nonepileptic seizures. A Reeve, J Schultz

P19. Treatment of acute ischemic stroke: does it impact neuropsychiatric outcome? CA Anderson, DB Arciniegas, CM Filley

P20. Quality of life and mental health in Parkinson's disease. KE Anderson, CG Vaughan, LM Shulman

P21. Effects of obsessive and compulsive symptoms in Huntington's disease. KE Anderson, JS Paulsen

P22. Neurological signs and cognitive function discriminate between adolescents with and without psychosis. DB Arciniegas, DC Rojas, M Ramos, ML Reite

P23. Axis I psychopathology masquerading as multiple sclerosis. KM Brousseau, DB Arciniegas, MJ Carmosino, JR Corboy

P24. Personality in essential tremor. A Chatterjee, EC Jurewicz, LM Applegate, ED Louis

P25. Progression of cerebral atrophy and cognitive decline in mild cognitive impairment. H Chertkow, S Murtha, E Churchill, D Gold, V Whitehead

P26. Validation of the Dementia Severity Scale (DSS): a new scale to assess dementia severity in affected patients living in a community setting. P Moriarty, MS Drelich, L Kleinman, K Coyne, PD Harvey, M Chen, DF Mirski

P27. Psychiatric symptoms in pre-symptomatic, gene-positive Huntington's disease: preliminary results from the PREDICT-HD study. K Duff, DR Langbehn, C Nehl, LJ Beglinger, JS Paulsen, the PREDICT-HSG Investigators

P28. Pharmacokinetic and pharmacodynamic aspects of extended-release bupropion in adult ADHD. JP Horrigan, DF Connor, BR Haight, KD Hampton

P29. Attentional inhibition and memory retrieval of ignored unfamiliar emotional faces in individuals with anxiety disorders. Y Hung, S Hsieh, H Ko

P30. The introduction of a psychosocial intervention, a “treatment mall,” has a gender-dependent effect on the need for restrictive interventions. JE Kraus, SL Webster, BB Sheitman

P31. Anticonvulsant medication for impulsive aggression: an outcome study. L Fisher, D Matthews

P32. Comparability of results from full and short-form versions of the Personality Assessment Inventory among patients referred for neuropsychological examinations. RI Naugle, RM Busch, J Goldyn

P33. Multiple sclerosis and alcohol: a study of problem drinking. S Quesnel, A Feinstein

P34. Open-label quetiapine in posttraumatic stress disorder: analysis of sleep data. S Robert, MB Hamner, S Kose, HG Ulmer, SE Deitsch, JP Lorberbaum

P35. Potential benefits of quetiapine in the treatment of substance use disorders: 1-year follow-up. SP Sattar, DR Wilson

P36. Structured mental health first-aid intervention in the ER with injured survivors of suicide-bombing terror attacks. S Schreiber, OT Dolberg, A Leor, H Rapoport, CG Pick, M Bloch

P37. Predicting response to methylphenidate in central pontine myelinolysis Arciniegas, David, Thomas P. Beresford, Lori Clapp

P38. Cognitive, behavioral, and EEG effects of levetiracetam in pediatric developmental disorders of attention and learning. D Duane, G Heimburger, D Duane, R White

P39. Co-morbid behavioral disorders in children with learning disabilities. Y Frank

P40. Relative hand skill, mixed handedness and nonverbal I.Q. in boys in India. PSB Sarma

P41. Comparison of mood symptoms associated with cerebellar lesions in childhood. SB Turkel, VL Brumm, WG Mitchell, CJ Tavare

P42. Potential benefits of quetiapine in the treatment of substance use disorders: 1-year follow-up. SP Sattar, DR Wilson

P1. Neural correlates of changes in the automaticity of attitudes toward gender. L Mah, CF Manly, J Grafman

P2. Does anticholinesterase (AChE) therapy have a differential effect on brain function and learning in Parkinson's disease? M Mentis, D Delalot, P Mattis, M Gordon, M Gudesblatt, V Dhawan, A Feigin, C Edwards, D Eidelberg

P3. Brain activation on a modified counting Stroop task in MS patients: an fMRI study. JJ Randolph, HA Wishart, RM Roth, KR Schuschu, BC McDonald, JW MacDonald, AC Mamourian, LH Kasper, AJ Saykin

P4. Brain activation during the counting Stroop in bipolar I disorder: an fMRI study. RM Roth, JJ Randolph, AJ Saykin, LA Flashman, HS Pixley, SM Ricketts, HA Wishart, AC Mamourian

P5. The effect of vascular lesion on regional cerebral blood flow in depressed older adults. T Fujito, A Tateno, S Mizumura, K Shimoda, M Kimura, Y Okubo

P6. Regional cerebral blood flow in patients with oral pain. R Arakawa, A Tateno, S Mizumura, Y Okubo

P7. Regional cerebral blood flow in patients with abnormal oral sensation. A Tateno, R Arakawa, S Mizumura, K Shimoda, Y Okubo

P8. Obsessive-compulsive symptoms in at-risk gene negative, presymptomatic gene positive, and symptomatic patients with Huntington's disease. L Beglinger, K Duff, DR Langbehn, C Nehl, JS Paulsen, the PREDICT-HSG Investigators

P9. Ecological validity of the neuropsychological assessment battery driving scenes test. LB Brown, RA Stern, DA Cahn-Weiner, B Rogers, MA Davis, MC Lannon, C Maxwell, T Souza, T White, BR Ott

P10. The effects of psycho-stimulants on cognitive development of students with ADHD. K Cates, P Cates, D Woodhouse

P11. Psychometric and clinical properties of a new, computerized neurocognitive screening battery. CT Gualtieri, LG Johnson, KB Benedict

P12. Predictors of clock reading, drawing, and setting performance. R Hilsabeck, D Stroud, SR Mooney, H Rodgers, M Trumbo, C Stewart, B Rey, S Herin, A Gilmore

P13. Cognitive deficits in patients with chronic hepatitis C. RC Hilsabeck, SR Mooney, E Variyam, P Malek-Ahmadi, D Stroud, L Holcomb, H Rodgers, C Stewart, JE Hancock, E Ghandour

P14. Risky decision making in HIV infected adults. CH Hinkin, DJ Hardy, AJ Levine, SA Castellon, MN Lam, KI Mason, R Schug, M Robinet, RS Durvasula

P15. Attenuating demographic influences on FAS and animal naming in a psychiatric sample. SE O'Bryant, JR O'Jile

P16. The California Verbal Learning Test-Children's Version: impact of verbal knowledge, IQ, and demographic variables. JR O'Jile, SE O'Bryant

P17. The influence of mood, IQ, and demographic variables on auditory consonant trigrams. JR O'Jile, SE O'Bryant

P18. Anxiety and intellectual functioning in patients with anorexia nervosa. RL Reese, BD McDowell, DJ Moser, WA Bowers, AE Andersen, JD Bayless, JS Paulsen

P19. The Modified Perceived Deficits Questionnaire as a measure of metamemory in multiple sclerosis. KR Schuschu, HA Wishart, BC McDonald, JJ Randolph, LA Flashman, JC DeViva, LH Kasper, AJ Saykin

P20. MCI in the elderly and daily life technology. L Scheinkman, SJ Czaja

P21. Imaging anatomy of the limbic thalamus. KH Taber, LA Hayman, RA Hurley

P22. Cavum septum pellucidum in schizophrenia: symptom and neuropsychological correlates. LA Flashman, RM Roth, HS Pixley, HB Cleavinger, AJ Saykin, TW McAllister, RM Vidaver

P23. A vascular/inflammatory hypothesis of schizophrenia: clues from rheumatic fever. DR Hanson

P24. Cognitive syndromes in schizophrenia related to hippocampal deformities. G Heydebrand, L Wang, P Thompson, D Barch, J Csernansky

P25. Using recognition memory interference as a test of the binding memory deficit hypothesis in schizophrenia. M Lepage, M Menear, A Montoya, A Achim, S Lal

P26. Neurocognitive impairment, symptom load, and intellectual decline in schizophrenia. K Sundet, NI Landroe, J Egeland, A Asbjoernsen, A Lund, A Roness, KI Stordal, K Hugdahl, BR Rund

P27. Frequency of P50 nonsuppression among individuals with persistent attention and memory complaints following traumatic brain injury. BD Arciniegas, JL Topkoff, CA Anderson, CM Filley, LE Adler

P28. The effect of major depression on subjective and objective cognitive deficits in mild to moderate traumatic brain injury (TBI). L Chamelian, A Feinstein

P29. Contribution of pre-existing medical conditions and medications to risk of brain injury in older adults. RB Ferrell, EJ Wolinsky, LA Flashman, TW McAllister

P30. Effect of COMT Val/Met genotype on frontal lobe functioning in traumatic brain injury. LA Flashman, AJ Saykin, CH Rhodes, TW McAllister

P31. Concussive blast injuries to the brain in the United States Armed Forces during the global war on terrorism. LM French, LM Ryan, DL Warden

P32. Prolactin suppression as a marker for dopaminergic tone after the administration of bromocriptine in mild traumatic brain injury. CI Kauffman, TW McAllister, LA Flashman, BC McDonald, PK Shaw, K-TJ Yeo, AJ Saykin

P33. A multicenter, prospective investigation of inpatients with complicated mild traumatic brain injury. L Livingston, R Kennedy, J Marwitz, A Sander

P34. Predictors of psychological symptoms and treatment one year after traumatic brain injury: a population-based, epidemiological study. MD Horner, LA Labbate, PL Ferguson, K Tweedy, A Selassie

P35. Differential effect of COMT allele status on frontal activation associated with a dopaminergic agonist. TW McAllister, BC McDonald, LA Flashman, CH Rhodes, PK Shaw, R Ferrell, CI Kauffman, AJ Saykin

P36. Effects of guanfacine on working memory brain activation patterns in individuals with mild traumatic brain injury. TW McAllister, LA Flashman, AJ Saykin, BC McDonald, RB Ferrell, PK Shaw, BA Greenlee, KS Tanev, CI Kauffman

P37. Minimal traumatic brain injury (mTBI) produces cognitive deficits, behavioral disturbances and alteration of anxiety in mice. A Milman, R Weizman, S Schreiber, CG Pick

P38. Comparisons between deficit schizophrenia and post-TBI apathy. V Rao, JR Spiro, DJ Schretlen, SM Meyer, NG Cascella

P39. Post-TBI personality disorders. JR Spiro, CG Lyketsos, V Rao